Literature DB >> 341406

Immunoglobulin and complement inclusions in peripheral blood polymorphonuclear leucocytes of patients with bronchial carcinoma.

H M Jansen, T H The, G C de Gast, H A Huiges, M T Esselink, A M van der Wal, N G Orie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 341406      PMCID： PMC470817          DOI： 10.1136/thx.32.6.706

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  11 in total

1.  Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome.

Authors:  M E Costanza; V Pinn; R S Schwartz; L Nathanson
Journal:  N Engl J Med       Date:  1973-09-06       Impact factor: 91.245

2.  Immune complexes associated with neoplasia: presence of Epstein-Barr virus antigen-antibody complexes in Burkitt's lymphoma.

Authors:  M B Oldstone; A N Theofilopoulos; P Gunvén; G Klein
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

3.  Detection and radioassay of soluble circulating immune complexes using guinea pig peritoneal exudate cells.

Authors:  I I Onyewotu; E J Holborow; G D Johnson
Journal:  Nature       Date:  1974-03-08       Impact factor: 49.962

4.  Nephrotic syndrome in malignant disease of non-renal origin.

Authors:  L W Loughridge; M G Lewis
Journal:  Lancet       Date:  1971-02-06       Impact factor: 79.321

5.  Immunological studies in nephrotic syndrome associated with extrarenal malignant disease.

Authors:  M G Lewis; L W Loughridge; T M Phillips
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

6.  Immune complex diseases.

Authors:  F J Dixon
Journal:  J Invest Dermatol       Date:  1972-12       Impact factor: 8.551

7.  The Raji cell radioimmune assay for detecting immune complexes in human sera.

Authors:  A N Theofilopoulos; C B Wilson; F J Dixon
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

8.  Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes.

Authors:  H O Sjögren; I Hellström; S C Bansal; G A Warner; K E Hellström
Journal:  Int J Cancer       Date:  1972-03-15       Impact factor: 7.396

9.  Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.

Authors:  H O Sjögren; I Hellström; S C Bansal; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

10.  Renal deposition of soluble immune complexes in mice bearing B-16 melanoma. Characterization of complexes and relationship to tumor progress.

Authors:  P K Poskitt; T R Poskitt; J H Wallace
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307
View more
  7 in total

1.  Immunoglobulin classes in local immune complexes recovered by bronchoalveolar lavage in collagen vascular diseases.

Authors:  H M Jansen; A J Schutte; M van der Giessen; T H The
Journal:  Lung       Date:  1984       Impact factor: 2.584

2.  The primary immune response of patients with different stages of squamous-cell bronchial carcinoma.

Authors:  H M Jansen; T H The; G C de Gast; M T Esselink; G Pastoor; N G Orie
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

3.  Local immune complexes and inflammatory response in patients with chronic interstitial pulmonary disorders associated with collagen vascular diseases.

Authors:  H M Jansen; A J Schutte; J D Elema; M V Giessen; R P Reig; M A Leeuwen; H J Sluiter; T H The
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

4.  Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenon.

Authors:  J van der Maulen; A A Wouda; E Mandema; T H The
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

5.  Immune complexes in peripheral blood polymorphonuclear leucocytes of malignant melanoma patients.

Authors:  T H The; M van der Giessen; H A Huiges; H Schraffordt Koops; I van Wingerden
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

6.  Simultaneous occurrence of pulmonary interstitial fibrosis and alveolar cell carcinoma in one family.

Authors:  F Beaumont; H M Jansen; J D Elema; L P ten Kate; H J Sluiter
Journal:  Thorax       Date:  1981-04       Impact factor: 9.139

7.  Circulating immune complexes and autoantibodies in lung cancer.

Authors:  K Guy; U Di Mario; W J Irvine; A M Hunter; A Hadley; N W Horne
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.